PARIS, France, and CAMBRIDGE, Massachusetts, March 6th, 2025 – Epigene Labs, a techbio company focused on creating intelligence-augmenting solutions for precision oncology, today announced an expanded multi-year collaboration with Servier, an independent international pharmaceutical group. Building on a successful partnership initiated in oncology research, this ambitious expansion aims to provide access for Servier to a harmonized clinical and multi-omic data to fuel the pharmaceutical company’s disease modeling, biomarker identification, and patient selection strategies. To know more
